Name: Novartis AG (NVS) Earnings Call
Start: 2027-02-03

Recent quarters

Latest 4 quarters

Beat in 2 of 3 · beat then fell 0 · average move ⁦±1.9%⁩

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q3 FY2026 2026-10-27	2.46 / 2.25 +9.3%	$14.52B / $14.53B -0.1%	Calculated after the session closes
Q2 FY2026 2026-07-21	2.41 / 2.17 +11.1%	$14.41B / $14.07B +2.4%	+2.88% ⁦+2.05⁩ pts vs SPY
Q1 FY2026 2026-04-28	1.99 / 2.11 -5.7%	$13.11B / $13.44B -2.4%	+0.91% ⁦+1.40⁩ pts vs SPY
Q4 FY2025 2026-02-04	2.03 / 1.99 +2.0%	$13.34B / $13.70B -2.7%	+2.04% ⁦+2.52⁩ pts vs SPY

Reported / estimate

Q3 FY2026 · 2026-10-27Calculated after the session closes
EPS2.46 / 2.25+9.3%
Revenue$14.52B / $14.53B-0.1%
Q2 FY2026 · 2026-07-21+2.88%
EPS2.41 / 2.17+11.1%
Revenue$14.41B / $14.07B+2.4%
Q1 FY2026 · 2026-04-28+0.91%
EPS1.99 / 2.11-5.7%
Revenue$13.11B / $13.44B-2.4%
Q4 FY2025 · 2026-02-04+2.04%
EPS2.03 / 1.99+2.0%
Revenue$13.34B / $13.70B-2.7%

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Latest result

Reported today

⁦+9.3%⁩EPS Beat

2026-10-27Q3 FY2026

Calculated after the session closes

2027-02-03

In 99 daysQ4 FY2026Time not announced· Expected date